Ajanta Pharma (BOM:532331) EPS (Basic): ₹84.53 (TTM As of Mar. 2026)


BOM:532331 Ajanta Pharma Ltd BOM:532331
97 GF Score
Price ₹3,188.85
GF Value ₹3,129.04
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ajanta Pharma EPS (Basic)?

Ajanta Pharma BOM:532331 97 EPS (Basic) is ₹84.53 as of Mar. 2026. GuruFocus rates BOM:532331 with a GF Score™ of 97/100 and a GF Value™ of ₹3,129.04 (Fairly Valued). The stock has 4 warning signs investors should review.

Ajanta Pharma's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹21.35. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹84.53.

Ajanta Pharma's EPS (Diluted) for the three months ended in Mar. 2026 was ₹21.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹84.50.

Ajanta Pharma's EPS without NRI for the three months ended in Mar. 2026 was ₹21.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 84.50.

During the past 12 months, Ajanta Pharma's average EPS without NRIGrowth Rate was 23.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 24.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ajanta Pharma's highest 3-Year average EPS without NRI Growth Rate was 66.30% per year. The lowest was -2.70% per year. And the median was 27.30% per year.

Ajanta Pharma  (BOM:532331) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ajanta Pharma EPS (Basic) Related Terms

Ajanta Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Ajanta Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma EPS (Basic) Chart

Ajanta Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.97 45.89 64.82 73.56 84.53

Ajanta Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.00 20.44 20.83 21.91 21.35
BOM:532331
97GF Score
Ajanta Pharma Ltd BOM:532331
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajanta Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ajanta Pharma's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10560-0)/124.928
=84.53

Ajanta Pharma's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2667-0)/124.918
=21.35

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹84.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹84.53 mean?
Ajanta Pharma (BOM:532331) has a EPS (Basic) of ₹84.53 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ajanta Pharma and its competitors.
Is Ajanta Pharma's EPS (Basic) too high?
Ajanta Pharma's current EPS (Basic) is ₹84.53. Overall, Ajanta Pharma has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ajanta Pharma's EPS (Basic) compare to ZTS?
Ajanta Pharma's EPS (Basic) of ₹84.53 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ajanta Pharma and its competitors. Ajanta Pharma's current EPS (Basic) is ₹84.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajanta Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ajanta Pharma (BOM:532331) is currently considered Fairly Valued. The stock's GF Value™ is ₹3,129.04, compared to a current price of ₹3,188.85 — trading 1.9% above its estimated fair value. The current EPS (Basic) is ₹84.53. Ajanta Pharma's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ajanta Pharma (BOM:532331), the current EPS (Basic) is ₹84.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajanta Pharma (BOM:532331) Overvalued in 2026?

Based on GuruFocus' analysis, Ajanta Pharma stock appears to be overvalued. The current stock price of ₹3,188.85 is trading 1.9% above its estimated GF Value™ of ₹3,129.04. GuruFocus considers Ajanta Pharma to be Fairly Valued.

Key valuation signals for BOM:532331:

  • EPS (Basic): ₹84.53
  • GF Value™: ₹3,129.04 vs. price of ₹3,188.85 (1.9% above fair value)
  • GF Score™: 97/100 with 4 warning signs

No single metric tells the full story. See the BOM:532331 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajanta Pharma Business Description

Other Exchanges AJANTPHARM:India
Address M Vasanji Road, Ajanta Tower, 54-A, Chakala, Andheri East, Mumbai, MH, IND, 400 093
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
97GF Score

Get the complete analysis for BOM:532331

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,188.85
Price
₹3,129.04
GF Value